X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2442) 2442
Publication (203) 203
Book Review (23) 23
Book Chapter (21) 21
Conference Proceeding (8) 8
Newsletter (5) 5
Journal / eJournal (2) 2
Magazine Article (2) 2
Newspaper Article (2) 2
Web Resource (2) 2
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2021) 2021
male (1163) 1163
female (1111) 1111
adult (1079) 1079
oligodendroglioma (1069) 1069
middle aged (958) 958
index medicus (916) 916
clinical neurology (886) 886
oncology (865) 865
brain neoplasms - pathology (789) 789
gliomas (646) 646
aged (603) 603
oligodendroglioma - pathology (597) 597
brain neoplasms - genetics (541) 541
chemotherapy (530) 530
tumors (520) 520
prognosis (503) 503
glioma (493) 493
survival (472) 472
adolescent (451) 451
radiotherapy (439) 439
oligodendroglioma - genetics (422) 422
brain neoplasms - drug therapy (413) 413
surgery (391) 391
astrocytoma (387) 387
glioma - pathology (372) 372
glioblastoma (369) 369
cancer (365) 365
neurosciences (353) 353
brain neoplasms - therapy (347) 347
pathology (340) 340
medicine & public health (337) 337
oligodendroglioma - drug therapy (335) 335
child (332) 332
brain neoplasms - diagnosis (330) 330
temozolomide (315) 315
brain neoplasms - surgery (303) 303
magnetic resonance imaging (293) 293
brain neoplasms - mortality (292) 292
radiation-therapy (288) 288
retrospective studies (284) 284
brain tumors (282) 282
treatment outcome (280) 280
brain neoplasms - radiotherapy (278) 278
combined modality therapy (275) 275
anaplastic oligodendroglioma (274) 274
oligodendroglioma - diagnosis (268) 268
oligodendroglioma - surgery (259) 259
astrocytoma - pathology (253) 253
oligodendroglioma - therapy (252) 252
glioma - genetics (251) 251
neurology (246) 246
oligodendroglioma - radiotherapy (241) 241
brain cancer (237) 237
young adult (236) 236
mutation (218) 218
oligodendrogliomas (212) 212
brain-tumors (210) 210
glioma - drug therapy (207) 207
brain neoplasms - metabolism (206) 206
survival analysis (206) 206
oligodendroglioma - mortality (204) 204
astrocytomas (198) 198
immunohistochemistry (197) 197
analysis (185) 185
glioblastoma-multiforme (184) 184
phase-iii trial (184) 184
antineoplastic combined chemotherapy protocols - therapeutic use (183) 183
diagnosis (183) 183
survival rate (182) 182
chromosomes, human, pair 1 - genetics (177) 177
classification (175) 175
follow-up studies (175) 175
brain (172) 172
oligodendroglioma - metabolism (167) 167
animals (165) 165
child, preschool (164) 164
glioma - therapy (159) 159
dacarbazine - analogs & derivatives (156) 156
disease-free survival (156) 156
expression (155) 155
research (155) 155
low-grade glioma (153) 153
astrocytoma - drug therapy (151) 151
19q (150) 150
isocitrate dehydrogenase - genetics (149) 149
chromosome deletion (148) 148
glioblastoma - pathology (147) 147
care and treatment (146) 146
neurosurgery (142) 142
disease progression (141) 141
genetic aspects (140) 140
antineoplastic agents - therapeutic use (139) 139
astrocytoma - genetics (139) 139
glioma - radiotherapy (137) 137
chromosomes, human, pair 19 - genetics (136) 136
anaplastic oligodendrogliomas (134) 134
astrocytoma - radiotherapy (134) 134
glioma - diagnosis (134) 134
glioma - mortality (134) 134
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2236) 2236
French (75) 75
German (53) 53
Japanese (35) 35
Russian (18) 18
Spanish (13) 13
Czech (6) 6
Dutch (5) 5
Italian (5) 5
Polish (5) 5
Portuguese (5) 5
Hungarian (4) 4
Danish (3) 3
Chinese (1) 1
Korean (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 14, pp. 1344 - 1355
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2005, Volume 63, Issue 2, pp. 511 - 519
To develop a valid treatment strategy for recurrent high-grade gliomas using stereotactic hypofractionated reirradiation based on biologic imaging and... 
Recurrent gliomas | Reirradiation | SFRT | Amino acid PET and SPECT | Temozolomide | reirradiation | temozolomide | GLIOBLASTOMA-MULTIFORME | PHASE-II | C-11-METHIONINE | CEREBRAL GLIOMA | recurrent gliomas | SPECT | MALIGNANT GLIOMA | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | amino acid PET and SPECT | EXPERIENCE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | BRAIN | Astrocytoma - radiotherapy | Neoplasm Recurrence, Local - radiotherapy | Tomography, Emission-Computed, Single-Photon - methods | Prospective Studies | Dacarbazine - therapeutic use | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Glioblastoma - radiotherapy | Glioma - radiotherapy | Oligodendroglioma - radiotherapy | Glioblastoma - diagnostic imaging | Gliosarcoma - drug therapy | Neoplasm Recurrence, Local - diagnostic imaging | Astrocytoma - drug therapy | Dacarbazine - analogs & derivatives | Statistics, Nonparametric | Adult | Dose Fractionation | Female | Oligodendroglioma - drug therapy | alpha-Methyltyrosine | Methionine | Combined Modality Therapy | Gliosarcoma - radiotherapy | Positron-Emission Tomography - methods | Astrocytoma - diagnostic imaging | Stereotaxic Techniques | Antineoplastic Agents, Alkylating - therapeutic use | Glioma - diagnostic imaging | Analysis of Variance | Aged | Glioblastoma - drug therapy | Gliosarcoma - diagnostic imaging | Glioma - drug therapy | Oligodendroglioma - diagnostic imaging | Pets | Chemotherapy | Gliomas | Radiation | Tomography | Amino acids | Diagnostic imaging | Radiotherapy | Cancer
Journal Article
Journal Article
World Neurosurgery, ISSN 1878-8750, 07/2017, Volume 103, pp. 504 - 516
To summarize the clinical and radiologic features of pediatric basal ganglia region tumors (PBGRT) in correlation with their histopathologic findings to reduce... 
Germ cell tumor | Basal ganglia region tumor | Pediatric | Astrocytoma | SURGERY | PROGNOSTIC-FACTORS | GERM-CELL TUMORS | LOW-GRADE GLIOMAS | CHILDRENS ONCOLOGY GROUP | CLINICAL NEUROLOGY | BRAIN-TUMORS | OUTCOME ANALYSIS | PILOCYTIC ASTROCYTOMAS | MRI FEATURES | SINGLE-INSTITUTION | GERMINOMA | Neurocytoma - therapy | Astrocytoma - therapy | Brain Neoplasms - diagnostic imaging | Humans | Child, Preschool | Male | Brain Neoplasms - complications | Chemoradiotherapy | Neuroectodermal Tumors, Primitive - diagnostic imaging | Teratoma - metabolism | Biomarkers, Tumor - metabolism | Teratoma - therapy | Child | Astrocytoma - metabolism | Neuroectodermal Tumors, Primitive - metabolism | Ependymoma - complications | Ganglioglioma - diagnostic imaging | Teratoma - diagnostic imaging | Neuroectodermal Tumors, Primitive - therapy | Astrocytoma - diagnostic imaging | Rhabdoid Tumor - complications | Teratoma - complications | Dizziness - etiology | Oligodendroglioma - therapy | Basal Ganglia Diseases - metabolism | Basal Ganglia Diseases - therapy | Adolescent | Brain Neoplasms - therapy | Seizures - etiology | Basal Ganglia Diseases - diagnostic imaging | Ganglioglioma - metabolism | Neoplasms, Germ Cell and Embryonal - therapy | Oligodendroglioma - diagnostic imaging | Headache - etiology | Lymphoma - diagnostic imaging | Infant | Ependymoma - therapy | Brain Neoplasms - metabolism | Neoplasms, Neuroepithelial - complications | Astrocytoma - complications | Ganglioglioma - complications | Lymphoma - metabolism | Neurosurgical Procedures | Molecular Diagnostic Techniques | Lymphoma - therapy | Ganglioglioma - therapy | Rhabdoid Tumor - diagnostic imaging | Oligodendroglioma - metabolism | Female | Neoadjuvant Therapy | Neoplasms, Germ Cell and Embryonal - complications | Retrospective Studies | Rhabdoid Tumor - metabolism | Paresis - etiology | Neurocytoma - complications | Neurocytoma - metabolism | Caudate Nucleus - surgery | Neoplasms, Germ Cell and Embryonal - metabolism | Ependymoma - diagnostic imaging | Oligodendroglioma - complications | Basal Ganglia Diseases - complications | Ependymoma - metabolism | Neoplasms, Germ Cell and Embryonal - diagnostic imaging | Neoplasms, Neuroepithelial - therapy | Neuroectodermal Tumors, Primitive - complications | Rhabdoid Tumor - therapy | Caudate Nucleus - diagnostic imaging | Neurocytoma - diagnostic imaging | Lymphoma - complications | Neoplasms, Neuroepithelial - diagnostic imaging | Second-Look Surgery | Pediatrics | Tumors | Chorionic gonadotropin | Gliomas | Adjuvant treatment | Nuclear magnetic resonance spectroscopy | Lymphomas | Glycoproteins | Health aspects | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. e315 - e329
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 91, Issue 3, pp. 497 - 504
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 2, pp. 390 - 397
Purpose We analyzed outcomes of simultaneous integrated boost (SIB) intensity-modulated radiotherapy (IMRT) in patients with high-grade gliomas, compared with... 
Radiology | Hematology, Oncology and Palliative Medicine | Intensity-modulated radiotherapy | Glioma | Toxicity | Simultaneous integrated boost | Survival | Patterns of failure | GLIOBLASTOMA-MULTIFORME | PHASE-III | RADIATION-THERAPY | ADJUVANT TEMOZOLOMIDE | TRIAL | IRRADIATION | ONCOLOGY | CONCOMITANT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CARMUSTINE | TUMOR VOLUME | Astrocytoma - radiotherapy | Dacarbazine - therapeutic use | Humans | Middle Aged | Brain Neoplasms - pathology | Male | Oligodendroglioma - radiotherapy | Young Adult | Astrocytoma - pathology | Astrocytoma - drug therapy | Dacarbazine - analogs & derivatives | Adult | Female | Retrospective Studies | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Astrocytoma - mortality | Oligodendroglioma - drug therapy | Radiotherapy Dosage | Oligodendroglioma - mortality | Radiotherapy, Intensity-Modulated - methods | Survival Rate | Tumor Burden | Brain Neoplasms - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Oligodendroglioma - pathology | Aged | Care and treatment | Radiotherapy | Gliomas | Analysis | Index Medicus | GLIOMAS | NEOPLASMS | TOXICITY | MEDICINE | NUCLEAR MEDICINE | NERVOUS SYSTEM DISEASES | FRACTIONATED IRRADIATION | DISEASES | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | RADIOLOGY | SURVIVAL CURVES
Journal Article
Neuro-Oncology, ISSN 1522-8517, 04/2009, Volume 11, Issue 2, pp. 167 - 175
The primary objectives of this phase II study were to evaluate the use of preirradiation temozolomide followed by concurrent temozolomide and radiotherapy (RT)... 
temozolomide | SURVIVAL | 1p/19q loss of heterozygosity | oligodendroglioma | MGMT | CHROMOSOME ARMS 1P | 19Q | PROCARBAZINE | TUMORS | CHEMOTHERAPY | CLINICAL NEUROLOGY | GLIOBLASTOMA | ONCOLOGY | PREDICTORS | EUROPEAN-ORGANIZATION | RADIOTHERAPY | RTOG | Astrocytoma - radiotherapy | Prognosis | Astrocytoma - therapy | Dacarbazine - therapeutic use | Humans | Middle Aged | Oligodendroglioma - diagnosis | DNA Repair Enzymes - genetics | Male | Oligodendroglioma - radiotherapy | Young Adult | Chromosomes, Human, Pair 19 - genetics | DNA Methylation | Tumor Suppressor Proteins - genetics | Astrocytoma - drug therapy | Dacarbazine - analogs & derivatives | Adult | Dose Fractionation | Female | Antineoplastic Agents, Phytogenic - therapeutic use | Brain Neoplasms - radiotherapy | Chromosomes, Human, Pair 1 - genetics | Astrocytoma - diagnosis | Oligodendroglioma - drug therapy | Chromosome Deletion | Promoter Regions, Genetic | Brain Neoplasms - diagnosis | Neoplasm Recurrence, Local - therapy | In Situ Hybridization, Fluorescence | Survival Rate | Treatment Outcome | Combined Modality Therapy | Neoplasm Recurrence, Local - diagnosis | Brain Neoplasms - drug therapy | DNA Modification Methylases - genetics | Oligodendroglioma - therapy | Adolescent | Brain Neoplasms - therapy | Aged | Index Medicus | Clinical Investigations | 19q loss of heterozygosity | oligo-dendroglioma
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 06/2018, Volume 101, Issue 2, pp. 334 - 343
Journal Article